×

HSGX – histogenics corp common (US:NASDAQ)

DELAYED
$ usd
Volume Shares
1 Day Range
Volume Ratio
52 Week High
52 Week Low
VWAP
Today’s Volatility
20 Day Volatility
Open
Prior Close
1D
5D
1M
3M
YTD
1Y
3Y
1 Day HSGX SPY QQQ SPX
Date Time Symbol Headline Impact
8/22 08:29 am hsgx Histogenics Corporation (NASDAQ: HSGX) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating. Low
8/15 11:23 pm hsgx Histogenics Corporation (NASDAQ: HSGX) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $2.00 price target on the stock. Low
8/11 04:02 pm hsgx Histogenics Corporation (NASDAQ: HSGX) had its "buy" rating re-affirmed by analysts at Canaccord Genuity. They now have a $4.00 price target on the stock. Neutral
8/11 08:03 am hsgx Histogenics Corporation (NASDAQ: HSGX) was given a new $4.00 price target on by analysts at HC Wainwright. They now have a "buy" rating on the stock. Low
8/10 06:30 am hsgx Histogenics Corporation Announces Second Quarter 2017 Financial and Operating Results Low
7/27 08:30 am hsgx Histogenics Corporation to Announce Second Quarter 2017 Financial Results on August 10, 2017 Low
7/26 08:30 am hsgx Histogenics Corporation to Present at the 37th Annual Canaccord Genuity Growth Conference Low
7/12 09:42 pm hsgx Histogenics Corporation (NASDAQ: HSGX) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating. Medium
7/11 08:30 am hsgx Histogenics Announces Publication of Data From Collagen and Chondrocyte 3-D Bioprinting Study Low
6/27 04:01 pm hsgx Histogenics Completes Enrollment for Phase 3 Clinical Trial of Neocart® to Treat Knee Cartilage Damage Low
6/5 08:30 am hsgx Histogenics Corporation Announces the Appointment of Donald Haut, Ph.D. as Chief Business Officer Low
5/16 11:49 pm hsgx Histogenics Corp (NASDAQ: HSGX) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $2.00 price target on the stock. Low
5/16 08:30 am hsgx Histogenics Corporation to Present at Upcoming Industry Conferences Neutral
5/15 08:30 am hsgx Histogenics Corporation Receives Innovation Award Neutral
5/11 05:12 pm hsgx Histogenics Corp (NASDAQ: HSGX) had its "buy" rating re-affirmed by analysts at Canaccord Genuity. They now have a $4.00 price target on the stock. Low
5/11 12:35 pm hsgx Histogenics' (HSGX) CEO Adam Gridley on Q1 2017 Results - Earnings Call Transcript [Seeking Alpha] Low
5/8 06:30 am hsgx Histogenics Announces Agreement With the Japan Pharmaceuticals and Medical Devices Agency Regarding Japanese Regulatory Pathway for NeoCart® Low
4/27 08:30 am hsgx Histogenics Corporation To Announce First Quarter 2017 Financial Results on May 11, 2017 Low
4/24 04:15 pm hsgx Histogenics Corporation to Present at 5th Annual Cell & Gene Therapy Investor Day on April 27, 2017 Medium
3/29 08:30 am hsgx Histogenics Corporation to Present at Needham & Company’s 16th Annual Healthcare Conference Medium
3/21 12:56 pm hsgx Histogenics Corp (NASDAQ: HSGX) was given a new $4.00 price target on by analysts at HC Wainwright. They now have a "buy" rating on the stock. Low
3/16 01:05 pm hsgx Histogenics' (HSGX) CEO Adam Gridley on Q4 2016 Results - Earnings Call Transcript [Seeking Alpha] Low
3/15 03:15 pm hsgx Histogenics Presents (HSGX) At Canaccord Genuity 2017 Musculoskeletal Conference [Seeking Alpha] Low
3/2 08:30 am hsgx Histogenics Corporation to Announce 2016 Financial Results on March 16, 2017 Low
2/23 08:30 am hsgx Histogenics Corporation to Present at Upcoming Investor Conferences Low
2/2 01:20 pm hsgx Histogenics: This $1 Stock Is Trading Below Cash Value And Offers Significant Upside Potential [Seeking Alpha] Medium
1/23 02:19 pm hsgx Histogenics Corp. (NASDAQ: HSGX) was given a new $5.00 price target on by analysts at Canaccord Genuity. They now have a "buy" rating on the stock. Low
1/17 11:27 pm hsgx Histogenics Corporation (NASDAQ: HSGX) was downgraded by analysts at Zacks Investment Research from a "strong-buy" rating to a "hold" rating. Medium
1/11 04:05 pm hsgx Histogenics Announces Publication of MRI Data From NeoCart® Phase 1 and Phase 2 Clinical Trials in the American Journal of Sports Medicine Medium
12/19 07:11 am hsgx Histogenics Corp. (NASDAQ: HSGX) is now covered by analysts at HC Wainwright. They set a "buy" rating and a $3.50 price target on the stock. High
11/22 12:02 am hsgx Histogenics Corp. (NASDAQ: HSGX) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $2.50 price target on the stock. Low
11/21 10:00 am hsgx Histogenics faces delisting from Nasdaq; shares down 5% [Seeking Alpha] Medium
11/11 05:25 pm hsgx Histogenics' (HSGX) CEO Adam Gridley on Q3 2016 Results - Earnings Call Transcript [Seeking Alpha] Medium
11/10 06:35 am hsgx Histogenics  misses by $0.21 [Seeking Alpha] Medium
10/24 09:24 am hsgx BRIEF-Histogenics provides Neocart phase 3 clinical trial enrollment update [Reuters] Medium
10/19 11:44 pm hsgx Histogenics Corp. (NASDAQ: HSGX) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating. Low
10/13 08:30 am hsgx Histogenics Corporation to Ring the Nasdaq Stock Market Closing Bell Low
10/6 04:05 pm hsgx Histogenics Corporation Announces Addition of Dr. Lawrence Bonassar of Cornell University to Its Scientific Advisory Board Medium
9/29 04:05 pm hsgx Histogenics Corporation Closes $30.0 Million Private Placement Low
9/26 08:30 am hsgx Histogenics Corporation to Present at the 2016 Cell & Gene Meeting on the Mesa Low
9/19 07:47 am hsgx Histogenics Corp. (NASDAQ: HSGX) had its price target lowered by analysts at Needham & Company LLC from $11.00 to $8.00. They now have a "buy" rating on the stock. Medium
9/16 07:22 am hsgx BRIEF-Histogenics Corporation announces $30 million private placement [Reuters] Medium
9/7 08:18 am hsgx Histogenics Corp. (NASDAQ: HSGX) was downgraded by analysts at William Blair from an "outperform" rating to a "market perform" rating. High
8/31 08:30 am hsgx Histogenics Corporation to Present at the 18th Annual Rodman & Renshaw Global Investment Conference Medium
8/26 10:23 pm hsgx Histogenics Corp. (NASDAQ: HSGX) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $3.25 price target on the stock. Low
Date Time Symbol Company Name Action %Chg
8/10 06:30 am HSGX histogenics corp common BEAT -0.4%
5/11 06:30 am HSGX histogenics corp common BEAT 1.8%
3/16 06:30 am HSGX histogenics corp common BEAT 0.6%
11/10 06:30 am HSGX histogenics corp common MISS -8.6%
Date Time Action From To Firm Impact %CHG DETAILS
8/22 08:29 am Downgrades Buy Hold Zacks Investment Research Low -2.2%
8/15 11:23 pm Upgrades Hold Buy Zacks Investment Research Low -0.2%
8/11 04:02 pm Reiterates Buy Canaccord Genuity 0.0%
7/12 09:42 pm Downgrades Buy Hold Zacks Investment Research Medium 3.4%
5/16 11:49 pm Upgrades Hold Buy Zacks Investment Research Low -1.5%
5/11 05:12 pm Reiterates Buy Canaccord Genuity Low -1.2%
1/17 11:27 pm Downgrades Strong-Buy Hold Zacks Investment Research Medium -3.5%
12/19 07:03 am Initiates BUY H.C. WAINWRIGHT High 13.9%
11/22 12:02 am Upgrades Hold Buy Zacks Investment Research Low -1.3%
10/19 11:44 pm Downgrades Buy Hold Zacks Investment Research Low 1.1%
9/7 08:18 am Downgrades Outperform Market Perform William Blair High 17.9%
8/26 10:23 pm Upgrades Hold Buy Zacks Investment Research Low -0.3%
Date Time Symbol Headline Impact
8/17 05:01 pm hsgx Form 4 HISTOGENICS CORP For: Aug 16 Filed by: GILL DAVID N Low
8/10 04:08 pm hsgx Form 10-Q HISTOGENICS CORP For: Jun 30 Low
8/10 08:31 am hsgx Form 8-K HISTOGENICS CORP For: Aug 10 Low
7/11 12:01 pm hsgx Form SC 13G HISTOGENICS CORP Filed by: ARMISTICE CAPITAL, LLC Low
6/27 04:32 pm hsgx Form 8-K HISTOGENICS CORP For: Jun 27 Low
6/26 05:01 pm hsgx Form 8-K HISTOGENICS CORP For: Jun 23 Low
6/14 05:01 pm hsgx Form 4 HISTOGENICS CORP For: Jun 13 Filed by: JOHNSON JOHN Low
6/13 05:02 pm hsgx Form 8-K HISTOGENICS CORP For: Jun 13 Medium
6/6 05:01 pm hsgx Form 3 HISTOGENICS CORP For: Jun 05 Filed by: Haut Donald Low
5/19 05:16 pm hsgx Form 10-Q/A HISTOGENICS CORP For: Mar 31 Low
5/17 05:02 pm hsgx Form 4 HISTOGENICS CORP For: May 16 Filed by: GILL DAVID N Low
5/11 04:10 pm hsgx Form 10-Q HISTOGENICS CORP For: Mar 31 Low
5/11 07:01 am hsgx Form 8-K HISTOGENICS CORP For: May 11 Low
5/8 07:01 am hsgx Form 8-K HISTOGENICS CORP For: May 08 High
4/27 07:31 am hsgx Form DEF 14A HISTOGENICS CORP For: Jun 13 Low
3/31 06:02 am hsgx Form EFFECT HISTOGENICS CORP Low
3/27 04:06 pm hsgx Form 8-K HISTOGENICS CORP For: Mar 24 Low
3/16 04:09 pm hsgx Form 10-K HISTOGENICS CORP For: Dec 31 Low
3/16 07:31 am hsgx Form 8-K HISTOGENICS CORP For: Mar 16 Low
2/15 05:57 pm hsgx Form 4 HISTOGENICS CORP For: Feb 14 Filed by: Kennedy Stephen Richard Low
2/14 11:25 am hsgx Form SC 13G/A HISTOGENICS CORP Filed by: FMR LLC Low
2/2 12:41 pm hsgx Form SC 13D/A HISTOGENICS CORP Filed by: SPLIT ROCK PARTNERS II, LP Medium
1/27 04:20 pm hsgx Form 4 HISTOGENICS CORP For: Dec 13 Filed by: SPLIT ROCK PARTNERS II, LP Medium
1/12 11:27 am hsgx Form SC 13G/A HISTOGENICS CORP Filed by: SABBY MANAGEMENT, LLC Medium
12/19 05:06 pm hsgx Form 4 HISTOGENICS CORP For: Dec 16 Filed by: GILL DAVID N Low
12/15 05:01 pm hsgx Form 4 HISTOGENICS CORP For: Dec 09 Filed by: GILL DAVID N Low
12/6 05:02 pm hsgx Form 4 HISTOGENICS CORP For: Dec 02 Filed by: Lewis Michael Low
12/5 05:00 pm hsgx Form 4 HISTOGENICS CORP For: Dec 02 Filed by: Wilmslow Estates Ltd Low
12/2 05:01 pm hsgx Form 4 HISTOGENICS CORP For: Dec 02 Filed by: Lieber Jonathan I Medium
11/22 05:00 pm hsgx Form 8-K HISTOGENICS CORP For: Nov 22 Medium
11/21 08:31 am hsgx Form 8-K HISTOGENICS CORP For: Nov 18 Low
11/10 04:09 pm hsgx Form 10-Q HISTOGENICS CORP For: Sep 30 Medium
11/10 07:31 am hsgx Form 8-K HISTOGENICS CORP For: Nov 10 Medium
11/4 05:12 pm hsgx Form 424B3 HISTOGENICS CORP Neutral
10/27 08:02 am hsgx Form PRER14A HISTOGENICS CORP High
10/24 08:30 am hsgx Form 8-K HISTOGENICS CORP For: Oct 24 Medium
10/12 05:26 pm hsgx Form D HISTOGENICS CORP Low
10/5 04:32 pm hsgx Form S-3 HISTOGENICS CORP Low
10/3 04:22 pm hsgx Form 4 HISTOGENICS CORP For: Sep 29 Filed by: SPLIT ROCK PARTNERS II, LP Low
9/29 04:31 pm hsgx Form 8-K HISTOGENICS CORP For: Sep 29 Low
9/16 08:31 am hsgx Form 8-K HISTOGENICS CORP For: Sep 15 Medium
9/15 01:13 pm hsgx Form CT ORDER HISTOGENICS CORP Medium
Stock Stats
News Stats
All News
News Wires
Media Monitoring
SEC Edgar Filings
Upgrades
Downgrades
Initiated
Reiterated
Last Earnings
Last Earnings EPS
Next Earnings
Order Stats
Sub-Penny

Odd Lot

Avg. bid-ask spread

Avg. bid / ask size


Shares at ask / bid


Off exchange

Don’t Miss Out On The Next BIG Stock Move

Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below:

Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies

If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.